Vanguard Personalized Indexing Management, LLC Blueprint Medicines Corp Transaction History
Vanguard Personalized Indexing Management, LLC
- $4.59 Billion
- Q1 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 3,791 shares of BPMC stock, worth $435,851. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,791
Previous 3,476
9.06%
Holding current value
$435,851
Previous $320,000
12.19%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BPMC
# of Institutions
316Shares Held
60.6MCall Options Held
634KPut Options Held
691K-
Black Rock Inc. New York, NY6.45MShares$741 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$725 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.25MShares$719 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$480 Million0.07% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.5MShares$287 Million6.2% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.87B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...